TacticScaleWhat Kimberly-Clark Does & How It Makes Money (KMB)
Updated October 2026 · reflects Kimberly-Clark's latest reported financials
Maker of everyday diapers, tissues, and personal care paper products. It earns revenue by manufacturing and selling branded, repeat-purchase personal care and tissue products through supermarkets, mass merchandisers, drugstores, warehouse clubs, distributors, and e-commerce.
How Kimberly-Clark makes money
It earns revenue by manufacturing and selling branded, repeat-purchase personal care and tissue products through supermarkets, mass merchandisers, drugstores, warehouse clubs, distributors, and e-commerce. A professional line also sells towels, wipers, soaps, and sanitizers to businesses and high-traffic public facilities.
What Kimberly-Clark does
Kimberly-Clark is a Dallas-based consumer staples company founded in 1872 that makes disposable personal care and paper products. It operates two segments: North America, which covers baby and child care, feminine and adult care, and tissue and paper products such as Kleenex, Scott, Cottonelle, and Viva; and International Personal Care, which focuses on diapers, feminine care, and adult care under brands like Huggies, Kotex, Goodfeel, Intimus, and Depend. Its products are mostly everyday necessities that people buy again and again, sold through major retailers, warehouse clubs, drugstores, distributors, and online. It also has a professional business that supplies wipers, towels, tissue, soaps, and sanitizers to workplaces, hotels, food service, and public facilities.
Products & services
- Huggies diapers and baby wipes
- Pull-Ups training pants
- Kleenex facial tissue
- Cottonelle and Scott bathroom tissue
- Kotex feminine care
- Depend and Poise incontinence care
What is Kimberly-Clark worth?
On an owner-earnings DCF, Kimberly-Clark's most-likely value is about $101 versus a recent price near $98 (3% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$63) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
C&S Paper (002511.SZ) · The Procter & Gamble (PG) · The Clorox (CLX)